BCHE and Mental deterioration: Current therapies for AD, such as treatment with cholinesterase inhibitors (e.g., galantamine, rivastigmine, and donepezil), immunotherapy agents (e.g., lecanemab and donanemab), or memantine, an N-methyl-D-aspartate receptor antagonist, only slow down cognitive decline, thereby reducing some cognitive and behavioral symptoms [101].